Herbert Yu Selected Research

Genetic Markers (Genetic Marker)

1/2020	Pro-inflammatory cytokine polymorphisms in ONECUT2 and HNF4A and primary colorectal carcinoma: a post genome-wide gene-lifestyle interaction study.
1/2014	The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905.
8/2010	A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herbert Yu Research Topics

Disease

80	Neoplasms (Cancer) 06/2022 - 05/2002
51	Breast Neoplasms (Breast Cancer) 06/2022 - 05/2002
23	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 02/2006
17	Obesity 01/2022 - 01/2008
17	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 09/2009
17	Ovarian Epithelial Carcinoma 04/2016 - 02/2006
15	Endometrial Neoplasms (Endometrial Cancer) 04/2021 - 04/2008
14	Carcinogenesis 10/2021 - 06/2003
10	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2015
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 05/2007
10	Disease Progression 02/2017 - 02/2006
7	Insulin Resistance 01/2021 - 02/2004
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2008
4	Adenocarcinoma 10/2021 - 01/2015
4	Adenocarcinoma of Lung 08/2021 - 01/2013
4	Neoplasm Metastasis (Metastasis) 11/2018 - 09/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 04/2006
3	Papillary Thyroid Cancer 01/2022 - 01/2017
3	Fanconi Anemia (Fanconi's Anemia) 11/2021 - 01/2015
3	Hemorrhage 01/2017 - 07/2014
3	Residual Neoplasm 02/2012 - 12/2006
2	Fibrosis (Cirrhosis) 01/2022 - 12/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2021 - 01/2015
2	Inflammation (Inflammations) 01/2021 - 12/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2018 - 02/2008
2	Liver Diseases (Liver Disease) 11/2018 - 02/2008
2	Carcinoma (Carcinomatosis) 08/2018 - 09/2005
2	Diabetes Mellitus 01/2017 - 07/2015

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
24	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 08/2002
19	Insulin-Like PeptidesIBA 01/2021 - 08/2002
18	Insulin-Like Growth Factor Binding Protein 3IBA 07/2016 - 08/2002
17	Long Noncoding RNAIBA 06/2022 - 04/2015
16	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2002
15	Biological ProductsIBA 06/2022 - 01/2007
15	Hormones (Hormone)IBA 06/2022 - 05/2003
15	Estrogens (Estrogen)FDA Link 01/2021 - 05/2003
13	Messenger RNA (mRNA)IBA 01/2021 - 10/2007
11	MicroRNAs (MicroRNA)IBA 06/2022 - 11/2007
11	Insulin-Like Growth Factor II (Somatomedin A)IBA 04/2016 - 08/2002
10	Insulin (Novolin)FDA Link 01/2021 - 01/2008
10	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 11/2003
8	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 05/2003
7	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021 - 08/2002
7	PlatinumIBA 12/2020 - 09/2005
6	ORALIT (ORS)IBA 01/2021 - 10/2003
6	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 05/2003
6	CytokinesIBA 01/2021 - 02/2009
5	RNA (Ribonucleic Acid)IBA 06/2022 - 02/2006
5	Eukaryotic Initiation Factor-4EIBA 08/2006 - 05/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2008
4	C-Reactive ProteinIBA 01/2021 - 02/2013
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 05/2002
4	Vitamin D FDA LinkGeneric 07/2020 - 01/2015
4	Estrogen ReceptorsIBA 01/2019 - 05/2002
4	ABO Blood-Group SystemIBA 01/2017 - 04/2010
4	Peptides (Polypeptides)IBA 04/2011 - 10/2007
4	SteroidsIBA 11/2003 - 05/2003
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 07/2014
3	LimoneneIBA 08/2021 - 01/2018
3	Sex Hormone-Binding GlobulinIBA 01/2021 - 06/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2009
3	Dietary Fats (Dietary Fat)IBA 01/2021 - 01/2020
3	CholesterolIBA 01/2021 - 10/2008
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2020 - 04/2013
3	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 11/2018
3	Genetic Markers (Genetic Marker)IBA 01/2020 - 08/2010
3	Blood Group Antigens (Blood Groups)IBA 06/2013 - 09/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 08/2011 - 11/2007
3	MitogensIBA 01/2009 - 10/2003
3	Estrogen Receptor alphaIBA 01/2007 - 02/2006
2	LipidsIBA 12/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 12/2021 - 02/2012
2	Plant ExtractsIBA 08/2021 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2021 - 10/2016
2	LDL CholesterolIBA 01/2021 - 10/2008
2	oxidized low density lipoproteinIBA 01/2021 - 10/2008
2	CateninsIBA 01/2021 - 11/2017
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 10/2008
2	HDL CholesterolIBA 01/2021 - 10/2008
2	8,11,14-Eicosatrienoic Acid (Dihomo-gamma-Linolenic Acid)IBA 12/2020 - 10/2015
2	Particulate MatterIBA 10/2020 - 01/2018
2	Epidermal Growth Factor (EGF)IBA 01/2020 - 06/2019
2	Oral ContraceptivesIBA 01/2020 - 07/2013
2	ErbB Receptors (EGF Receptor)IBA 06/2019 - 07/2016
2	Untranslated RNA (Noncoding RNA)IBA 06/2019 - 12/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2019 - 09/2018
2	CarcinogensIBA 11/2018 - 01/2014
2	Therapeutic UsesIBA 01/2018 - 02/2006
2	LigandsIBA 07/2016 - 05/2012
2	InterleukinsIBA 07/2016 - 02/2013
2	LeptinIBA 07/2016 - 02/2009
2	Nonesterified Fatty Acids (NEFA)IBA 01/2016 - 10/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 04/2013

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 12/2020 - 09/2005
10	Therapeutics 12/2021 - 06/2003
4	Cytoreduction Surgical Procedures 04/2013 - 04/2007
3	Radiotherapy 07/2011 - 08/2006
2	Aftercare (After-Treatment) 01/2018 - 04/2009